78 These findings have been replicated across multiple studies in animals and humans, with GLP-1R agonism consistently reducing intestinal TRLapoB 48 production and postprandial triglyceride excursions largely independent of weight loss
A lot of GLP-1s are being prescribed by untrained in obesity professionals, Levy says
500 .
Thats why doctors start with a low dose and increase it slowly, about every 4 weeks
Dose, rate of weight loss, baseline BMI, and individual reproductive hormone baseline all influence outcomes
A recent phase three program showed it improved A1C (a three-month average of blood sugar) more than comparators [the drugs it was tested against] and led to significant weight loss, with side effects mostly in the digestive tract (nausea, vomiting [and] diarrhea), like other GLP-1 drugs. Wegovy pill Orforglipron isnt the only pill-form GLP-1 generating excitement